|
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer
|
5R01CA193455-03
|
$86,504
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-05
|
$1,187,291
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining the role of endometrial cancer PP2A A-alpha mutations in tumorigenesis
|
1F30CA224979-01A1
|
$44,524
|
TAYLOR, SARAH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities - HER2 Expression in Prostate Cancer Disease Progression and Identification of Targeted Therapeutic Intervention
|
3U54CA143931-09S1
|
$100,235
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities - Social Epigenomic Risk Factors for Cancer among African Americans in South Los Angeles
|
3U54CA143931-09S2
|
$100,235
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143931-09
|
$1,821,596
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
Impact of hurricane-related stressors and responses on oncology care and health outcomes of women with gynecologic cancers from Puerto Rico and US Virgin Islands
|
1R21CA239457-01
|
$193,813
|
ORTIZ, ANA
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-05
|
$1,302,199
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-05
|
$357,057
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-05
|
$413,627
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-05
|
$7,938,884
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Nutrition and Physical Activity Assessment Study (NPAAS)
|
5R01CA119171-11
|
$791,418
|
NEUHOUSER, MARIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Behavioral Economics and Improving Chemotherapy Decisions for Advanced Cancer
|
5K24CA181510-05
|
$170,381
|
KEATING, NANCY
|
HARVARD MEDICAL SCHOOL
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-05
|
$562,579
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
5U10CA180802-05
|
$575,595
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer
|
5R01CA207240-02
|
$543,708
|
BAKKUM-GAMEZ, JAMIE
|
MAYO CLINIC ROCHESTER
|
|
First in-human PET imaging studies of NIS reporter [18F]BF4
|
5R01CA196975-03
|
$172,718
|
DEGRADO, TIMOTHY
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S1
|
$60,000
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S2
|
$171,085
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-44S3
|
$150,571
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-44
|
$5,755,389
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
N/A
|
National Institutes of Health
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$192,282
|
Annunziata, Christina
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Columbia, Missouri serum bank participant extended follow-up
|
ZIA CP010126 01103
|
$22,524
|
Benson, Gretchen
|
DCEG (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Cancer Risk in Myotonic Dystrophy
|
ZIA CP010144 10568
|
$153,082
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
In vivo Imaging Analysis of Steroid-Nuclear Receptor Function
|
ZIA BC 010308
|
$383,139
|
Hager, Gordon
|
CCR (NCI)
|
|
Endometrial cancer epidemiologic study
|
ZIA CP010126 03050
|
$3,273
|
Hoover, Robert
|
DCEG (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168 00020
|
$5,855,332
|
Hoover, Robert
|
DCEG (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$865,192
|
Hou, Steven
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$440,152
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$880,303
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$660,228
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Activating Cell Death Pathways in Breast Cancer Cells
|
ZIA SC 007263
|
$469,702
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
Cancer following radiotherapy for benign gynecologic disorders
|
ZIA CP010131 04021
|
$30,751
|
Little, Mark
|
DCEG (NCI)
|
|
The Incidence of Breast and other Cancers among Female Flight Attendants
|
ZIA CP010133 04077
|
$16,720
|
Little, Mark
|
DCEG (NCI)
|
|
Finnish Maternity Cohort
|
ZIA CP010126 10775
|
$67,634
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Risk Prediction & Related Topics
|
ZIA CP010188 10621
|
$25,013
|
Pfeiffer, Ruth
|
DCEG (NCI)
|
|
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
|
ZIA BC 005177
|
$35,532
|
Poirier, Miriam
|
CCR (NCI)
|
|
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
|
ZIA BC 010770
|
$65,987
|
Poirier, Miriam
|
CCR (NCI)
|
|
Intratumor heterogeneity and tumor evolution
|
ZIA BC 010834
|
$676,875
|
Ried, Thomas
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|